People – Nature Biotechnology
Recent moves of note in and around the biotech and pharma industries.
Recent moves of note in and around the biotech and pharma industries.
Scientists have developed a liquid biopsy test that detects early-stage colorectal cancer with 95% accuracy by analyzing RNA modifications from gut
Nature Biotechnology – High-content screening datasets are integrated within a shared latent space, enabling cross-dataset predictions.
Following the sequence and structure revolutions, predicting functionally relevant protein structure changes at scale remains an outstanding challenge. We introduce BioEmu, a deep learning system…
Nature Biotechnology – We developed low-input multiple methylation sequencing (LIME-seq) to detect RNA modifications in plasma cell-free RNA (cfRNA) and identified microbiome-derived RNA…
Organised by Nanjing University,Nature, Nature Communications, Nature Biotechnology, Nature Methods The Nature conference on “AI Augmented Biology” explores how the integration of artificial intelligence with…
Microbiome-derived cell-free RNA (cfRNA) is a superior marker of early colorectal cancer (CRC) than cfRNA or cell-free DNA (cfDNA) levels.
CRISPR cytosine base editors have been refined through directed evolution of enzyme recognition loops to enable highly precise DNA editing with minimal bystander effects. Researchers…
UChicago researchers have developed a new liquid biopsy test that uses RNA modifications to detect early-stage colorectal cancer with 95% accuracy.
Researchers from more than 50 international institutions have launched Open Problems, a collaborative open-source platform to benchmark and improve computational methods for single-cell genomics.
Nature Biotechnology – The gutting of US research funding represents a once-in-a-generation opportunity for Europe to boost world-class research deprioritized by the Trump administration.